Gaush Meditech Ltd
Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company's product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalm… Read more
Gaush Meditech Ltd (F7Y) - Total Liabilities
Latest total liabilities as of June 2025: €897.99 Million EUR
Based on the latest financial reports, Gaush Meditech Ltd (F7Y) has total liabilities worth €897.99 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Gaush Meditech Ltd - Total Liabilities Trend (2021–2024)
This chart illustrates how Gaush Meditech Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Gaush Meditech Ltd Competitors by Total Liabilities
The table below lists competitors of Gaush Meditech Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SILVER CROWN ROYALTIES INC.
NEO:SCRI
|
Canada | CA$1.44 Million |
|
Hwang-Kum Stee
KO:032560
|
Korea | ₩110.61 Billion |
|
PTT Synergy Group Bhd
KLSE:7010
|
Malaysia | RM1.31 Billion |
|
Vranken-Pommery Monopole Société Anonyme
PA:VRAP
|
France | €927.49 Million |
|
S Connect Co. LTD
KQ:096630
|
Korea | ₩110.30 Billion |
|
ZUARI INDUSTRIES LIMITED
NSE:ZUARIIND
|
India | ₹34.46 Billion |
|
NMC Resource Corporation
V:NRC
|
Canada | CA$105.41K |
|
TV Today Network Limited
NSE:TVTODAY
|
India | ₹1.91 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down Gaush Meditech Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.40 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.54 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Gaush Meditech Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Gaush Meditech Ltd (2021–2024)
The table below shows the annual total liabilities of Gaush Meditech Ltd from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €978.12 Million | -14.70% |
| 2023-12-31 | €1.15 Billion | -6.88% |
| 2022-12-31 | €1.23 Billion | -59.76% |
| 2021-12-31 | €3.06 Billion | -- |